| Target ID |
Target Type |
Target Name |
Target Organism |
Activity Type |
Activity Relation |
Value |
Unit |
Reference |
| NPT282 |
Individual protein |
MAP kinase ERK2 |
Homo sapiens |
Ki |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT14 |
Individual protein |
Tyrosine-protein kinase FYN |
Homo sapiens |
Ki |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT287 |
Individual protein |
Leukocyte common antigen |
Homo sapiens |
IC50 |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT289 |
Individual protein |
Serotonin 1b (5-HT1b) receptor |
Rattus norvegicus |
IC50 |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT294 |
Individual protein |
Serotonin 6 (5-HT6) receptor |
Homo sapiens |
Ki |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT295 |
Individual protein |
Serotonin transporter |
Homo sapiens |
Ki |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT286 |
Individual protein |
Receptor protein-tyrosine kinase erbB-2 |
Homo sapiens |
Ki |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT13 |
Individual protein |
Tyrosine-protein kinase LCK |
Homo sapiens |
Ki |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT267 |
Individual protein |
Neuropeptide Y receptor type 1 |
Homo sapiens |
Ki |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT145 |
Individual protein |
Mu opioid receptor |
Homo sapiens |
Ki |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT204 |
Individual protein |
Acetylcholinesterase |
Homo sapiens |
Ki |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT229 |
Individual protein |
Angiotensin II type 2 (AT-2) receptor |
Homo sapiens |
IC50 |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT235 |
Individual protein |
C-C chemokine receptor type 4 |
Homo sapiens |
Ki |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT110 |
Individual protein |
Cytochrome P450 2D6 |
Homo sapiens |
IC50 |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT243 |
Individual protein |
Dopamine D2 receptor |
Homo sapiens |
Ki |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT232 |
Individual protein |
Cannabinoid CB1 receptor |
Homo sapiens |
IC50 |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT216 |
Individual protein |
Adenosine A1 receptor |
Homo sapiens |
IC50 |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT253 |
Individual protein |
HMG-CoA reductase |
Homo sapiens |
Ki |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT260 |
Individual protein |
Melanocortin receptor 5 |
Homo sapiens |
Ki |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT265 |
Individual protein |
Muscarinic acetylcholine receptor M4 |
Homo sapiens |
Ki |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT263 |
Individual protein |
Muscarinic acetylcholine receptor M2 |
Homo sapiens |
AC50 |
> |
30000.0 |
nM |
PMID[37468498] |
| NPT299 |
Individual protein |
Androgen Receptor |
Rattus norvegicus |
AC50 |
> |
30000.0 |
nM |
PMID[37468498] |
| NPT212 |
Individual protein |
Cytochrome P450 2C9 |
Homo sapiens |
IC50 |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT109 |
Individual protein |
Cytochrome P450 3A4 |
Homo sapiens |
IC50 |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT243 |
Individual protein |
Dopamine D2 receptor |
Homo sapiens |
IC50 |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT108 |
Individual protein |
Estrogen receptor alpha |
Homo sapiens |
Ki |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT232 |
Individual protein |
Cannabinoid CB1 receptor |
Homo sapiens |
AC50 |
> |
30000.0 |
nM |
PMID[37468498] |
| NPT274 |
Individual protein |
Platelet activating factor receptor |
Homo sapiens |
IC50 |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT227 |
Individual protein |
Beta-3 adrenergic receptor |
Homo sapiens |
Ki |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT244 |
Individual protein |
Dopamine D3 receptor |
Homo sapiens |
Ki |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT301 |
Individual protein |
Vascular endothelial growth factor receptor 1 |
Homo sapiens |
IC50 |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT222 |
Individual protein |
Alpha-2a adrenergic receptor |
Homo sapiens |
AC50 |
> |
30000.0 |
nM |
PMID[37468498] |
| NPT232 |
Individual protein |
Cannabinoid CB1 receptor |
Homo sapiens |
Ki |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT249 |
Individual protein |
Glucocorticoid receptor |
Homo sapiens |
AC50 |
> |
30000.0 |
nM |
PMID[37468498] |
| NPT262 |
Individual protein |
Muscarinic acetylcholine receptor M1 |
Homo sapiens |
Ki |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT300 |
Individual protein |
Thromboxane-A synthase |
Homo sapiens |
Ki |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT223 |
Individual protein |
Alpha-2b adrenergic receptor |
Homo sapiens |
Ki |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT30 |
Individual protein |
Cyclooxygenase-1 |
Homo sapiens |
IC50 |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT31 |
Individual protein |
Cyclooxygenase-2 |
Homo sapiens |
IC50 |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT273 |
Individual protein |
Phosphodiesterase 5A |
Homo sapiens |
Ki |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT280 |
Individual protein |
Matrix metalloproteinase 9 |
Homo sapiens |
IC50 |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT286 |
Individual protein |
Receptor protein-tyrosine kinase erbB-2 |
Homo sapiens |
IC50 |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT290 |
Individual protein |
Serotonin 2a (5-HT2a) receptor |
Homo sapiens |
IC50 |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT277 |
Individual protein |
Caspase-1 |
Homo sapiens |
Ki |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT281 |
Individual protein |
MAP kinase ERK1 |
Homo sapiens |
IC50 |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT284 |
Individual protein |
Serine/threonine protein phosphatase 2B catalytic subunit, alpha isoform |
Homo sapiens |
IC50 |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT213 |
Individual protein |
Cytochrome P450 2C19 |
Homo sapiens |
Ki |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT241 |
Individual protein |
Cytochrome P450 2E1 |
Homo sapiens |
IC50 |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT225 |
Individual protein |
Beta-1 adrenergic receptor |
Homo sapiens |
IC50 |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT246 |
Individual protein |
Dopamine transporter |
Homo sapiens |
Ki |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT235 |
Individual protein |
C-C chemokine receptor type 4 |
Homo sapiens |
IC50 |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT246 |
Individual protein |
Dopamine transporter |
Homo sapiens |
IC50 |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT257 |
Individual protein |
Arachidonate 15-lipoxygenase |
Oryctolagus cuniculus |
Ki |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT230 |
Individual protein |
Bradykinin B2 receptor |
Homo sapiens |
Ki |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT239 |
Individual protein |
Cholecystokinin A receptor |
Homo sapiens |
Ki |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT285 |
Individual protein |
Epidermal growth factor receptor erbB1 |
Homo sapiens |
IC50 |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT1464 |
Individual protein |
Phosphodiesterase 4D |
Homo sapiens |
AC50 |
> |
30000.0 |
nM |
PMID[37468498] |
| NPT285 |
Individual protein |
Epidermal growth factor receptor erbB1 |
Homo sapiens |
Ki |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT276 |
Individual protein |
Angiotensin-converting enzyme |
Oryctolagus cuniculus |
IC50 |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT279 |
Individual protein |
Leukocyte elastase |
Homo sapiens |
IC50 |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT223 |
Individual protein |
Alpha-2b adrenergic receptor |
Homo sapiens |
AC50 |
> |
30000.0 |
nM |
PMID[37468498] |
| NPT242 |
Individual protein |
Dopamine D1 receptor |
Homo sapiens |
IC50 |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT218 |
Individual protein |
Adenosine A3 receptor |
Homo sapiens |
Ki |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT237 |
Individual protein |
Interleukin-8 receptor A |
Homo sapiens |
IC50 |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT291 |
Individual protein |
Serotonin 2b (5-HT2b) receptor |
Homo sapiens |
AC50 |
> |
30000.0 |
nM |
PMID[37468498] |
| NPT292 |
Individual protein |
Serotonin 2c (5-HT2c) receptor |
Homo sapiens |
AC50 |
> |
30000.0 |
nM |
PMID[37468498] |
| NPT303 |
Individual protein |
Vasopressin V1a receptor |
Homo sapiens |
AC50 |
> |
30000.0 |
nM |
PMID[37468498] |
| NPT300 |
Individual protein |
Thromboxane-A synthase |
Homo sapiens |
IC50 |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT252 |
Individual protein |
Histamine H2 receptor |
Homo sapiens |
Ki |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT230 |
Individual protein |
Bradykinin B2 receptor |
Homo sapiens |
IC50 |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT217 |
Individual protein |
Adenosine A2a receptor |
Homo sapiens |
Ki |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT221 |
Individual protein |
Alpha-1d adrenergic receptor |
Homo sapiens |
IC50 |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT226 |
Individual protein |
Beta-2 adrenergic receptor |
Homo sapiens |
Ki |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT227 |
Individual protein |
Beta-3 adrenergic receptor |
Homo sapiens |
IC50 |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT247 |
Individual protein |
Endothelin receptor ET-A |
Homo sapiens |
IC50 |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT290 |
Individual protein |
Serotonin 2a (5-HT2a) receptor |
Homo sapiens |
AC50 |
> |
30000.0 |
nM |
PMID[37468498] |
| NPT269 |
Individual protein |
Nitric-oxide synthase, brain |
Rattus norvegicus |
IC50 |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT271 |
Individual protein |
Delta opioid receptor |
Homo sapiens |
Ki |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT204 |
Individual protein |
Acetylcholinesterase |
Homo sapiens |
IC50 |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT217 |
Individual protein |
Adenosine A2a receptor |
Homo sapiens |
IC50 |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT219 |
Individual protein |
Alpha-1a adrenergic receptor |
Rattus norvegicus |
Ki |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT228 |
Individual protein |
Norepinephrine transporter |
Homo sapiens |
Ki |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT229 |
Individual protein |
Angiotensin II type 2 (AT-2) receptor |
Homo sapiens |
Ki |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT256 |
Individual protein |
Cysteinyl leukotriene receptor 1 |
Homo sapiens |
IC50 |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT277 |
Individual protein |
Caspase-1 |
Homo sapiens |
IC50 |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT260 |
Individual protein |
Melanocortin receptor 5 |
Homo sapiens |
IC50 |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT255 |
Individual protein |
Leukotriene C4 synthase |
Cavia porcellus |
IC50 |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT262 |
Individual protein |
Muscarinic acetylcholine receptor M1 |
Homo sapiens |
IC50 |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT263 |
Individual protein |
Muscarinic acetylcholine receptor M2 |
Homo sapiens |
IC50 |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT225 |
Individual protein |
Beta-1 adrenergic receptor |
Homo sapiens |
AC50 |
> |
30000.0 |
nM |
PMID[37468498] |
| NPT108 |
Individual protein |
Estrogen receptor alpha |
Homo sapiens |
AC50 |
> |
30000.0 |
nM |
PMID[37468498] |
| NPT299 |
Individual protein |
Androgen Receptor |
Rattus norvegicus |
IC50 |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT240 |
Individual protein |
Cytochrome P450 2A6 |
Homo sapiens |
IC50 |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT220 |
Individual protein |
Alpha-1b adrenergic receptor |
Rattus norvegicus |
IC50 |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT222 |
Individual protein |
Alpha-2a adrenergic receptor |
Homo sapiens |
Ki |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT264 |
Individual protein |
Muscarinic acetylcholine receptor M3 |
Homo sapiens |
IC50 |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT234 |
Individual protein |
C-C chemokine receptor type 2 |
Homo sapiens |
Ki |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT31 |
Individual protein |
Cyclooxygenase-2 |
Homo sapiens |
Ki |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT245 |
Individual protein |
Dopamine D4 receptor |
Homo sapiens |
Ki |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT225 |
Individual protein |
Beta-1 adrenergic receptor |
Homo sapiens |
Ki |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT239 |
Individual protein |
Cholecystokinin A receptor |
Homo sapiens |
IC50 |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT255 |
Individual protein |
Leukotriene C4 synthase |
Cavia porcellus |
Ki |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT257 |
Individual protein |
Arachidonate 15-lipoxygenase |
Oryctolagus cuniculus |
IC50 |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT261 |
Individual protein |
Monoamine oxidase A |
Homo sapiens |
IC50 |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT271 |
Individual protein |
Delta opioid receptor |
Homo sapiens |
IC50 |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT31 |
Individual protein |
Cyclooxygenase-2 |
Homo sapiens |
AC50 |
> |
30000.0 |
nM |
PMID[37468498] |
| NPT223 |
Individual protein |
Alpha-2b adrenergic receptor |
Homo sapiens |
IC50 |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT236 |
Individual protein |
C-C chemokine receptor type 5 |
Homo sapiens |
Ki |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT266 |
Individual protein |
Muscarinic acetylcholine receptor M5 |
Homo sapiens |
IC50 |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT266 |
Individual protein |
Muscarinic acetylcholine receptor M5 |
Homo sapiens |
Ki |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT269 |
Individual protein |
Nitric-oxide synthase, brain |
Rattus norvegicus |
Ki |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT263 |
Individual protein |
Muscarinic acetylcholine receptor M2 |
Homo sapiens |
Ki |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT264 |
Individual protein |
Muscarinic acetylcholine receptor M3 |
Homo sapiens |
Ki |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT270 |
Individual protein |
Nitric oxide synthase, inducible |
Mus musculus |
Ki |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT256 |
Individual protein |
Cysteinyl leukotriene receptor 1 |
Homo sapiens |
Ki |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT271 |
Individual protein |
Delta opioid receptor |
Homo sapiens |
AC50 |
> |
30000.0 |
nM |
PMID[37468498] |
| NPT289 |
Individual protein |
Serotonin 1b (5-HT1b) receptor |
Rattus norvegicus |
Ki |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT291 |
Individual protein |
Serotonin 2b (5-HT2b) receptor |
Homo sapiens |
IC50 |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT293 |
Individual protein |
Serotonin 4 (5-HT4) receptor |
Cavia porcellus |
IC50 |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT182 |
Individual protein |
Protein kinase C alpha |
Homo sapiens |
Ki |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT220 |
Individual protein |
Alpha-1b adrenergic receptor |
Rattus norvegicus |
Ki |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT213 |
Individual protein |
Cytochrome P450 2C19 |
Homo sapiens |
IC50 |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT241 |
Individual protein |
Cytochrome P450 2E1 |
Homo sapiens |
Ki |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT248 |
Individual protein |
Estrogen receptor beta |
Homo sapiens |
Ki |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT253 |
Individual protein |
HMG-CoA reductase |
Homo sapiens |
IC50 |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT228 |
Individual protein |
Norepinephrine transporter |
Homo sapiens |
IC50 |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT243 |
Individual protein |
Dopamine D2 receptor |
Homo sapiens |
AC50 |
> |
30000.0 |
nM |
PMID[37468498] |
| NPT267 |
Individual protein |
Neuropeptide Y receptor type 1 |
Homo sapiens |
IC50 |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT251 |
Individual protein |
Histamine H1 receptor |
Homo sapiens |
AC50 |
> |
30000.0 |
nM |
PMID[37468498] |
| NPT259 |
Individual protein |
Melanocortin receptor 4 |
Homo sapiens |
IC50 |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT275 |
Individual protein |
Progesterone receptor |
Bos taurus |
Ki |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT278 |
Individual protein |
Cathepsin G |
Homo sapiens |
IC50 |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT299 |
Individual protein |
Androgen Receptor |
Rattus norvegicus |
Ki |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT226 |
Individual protein |
Beta-2 adrenergic receptor |
Homo sapiens |
AC50 |
> |
30000.0 |
nM |
PMID[37468498] |
| NPT290 |
Individual protein |
Serotonin 2a (5-HT2a) receptor |
Homo sapiens |
Ki |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT293 |
Individual protein |
Serotonin 4 (5-HT4) receptor |
Cavia porcellus |
Ki |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT297 |
Individual protein |
Neurokinin 1 receptor |
Homo sapiens |
IC50 |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT237 |
Individual protein |
Interleukin-8 receptor A |
Homo sapiens |
Ki |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT275 |
Individual protein |
Progesterone receptor |
Bos taurus |
IC50 |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT182 |
Individual protein |
Protein kinase C alpha |
Homo sapiens |
IC50 |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT283 |
Individual protein |
MAP kinase p38 alpha |
Homo sapiens |
Ki |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT216 |
Individual protein |
Adenosine A1 receptor |
Homo sapiens |
Ki |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT222 |
Individual protein |
Alpha-2a adrenergic receptor |
Homo sapiens |
IC50 |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT233 |
Individual protein |
Carbonic anhydrase II |
Homo sapiens |
IC50 |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT279 |
Individual protein |
Leukocyte elastase |
Homo sapiens |
Ki |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT283 |
Individual protein |
MAP kinase p38 alpha |
Homo sapiens |
IC50 |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT288 |
Individual protein |
Serotonin 1a (5-HT1a) receptor |
Rattus norvegicus |
IC50 |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT296 |
Individual protein |
Sigma opioid receptor |
Homo sapiens |
Ki |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT270 |
Individual protein |
Nitric oxide synthase, inducible |
Mus musculus |
IC50 |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT272 |
Individual protein |
Kappa opioid receptor |
Homo sapiens |
Ki |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT273 |
Individual protein |
Phosphodiesterase 5A |
Homo sapiens |
IC50 |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT298 |
Individual protein |
Neurokinin 2 receptor |
Homo sapiens |
IC50 |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT298 |
Individual protein |
Neurokinin 2 receptor |
Homo sapiens |
Ki |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT145 |
Individual protein |
Mu opioid receptor |
Homo sapiens |
AC50 |
> |
30000.0 |
nM |
PMID[37468498] |
| NPT247 |
Individual protein |
Endothelin receptor ET-A |
Homo sapiens |
AC50 |
> |
30000.0 |
nM |
PMID[37468498] |
| NPT1163 |
Individual protein |
Glutamate (NMDA) receptor subunit zeta 1 |
Rattus norvegicus |
AC50 |
> |
30000.0 |
nM |
PMID[37468498] |
| NPT242 |
Individual protein |
Dopamine D1 receptor |
Homo sapiens |
AC50 |
> |
30000.0 |
nM |
PMID[37468498] |
| NPT217 |
Individual protein |
Adenosine A2a receptor |
Homo sapiens |
AC50 |
> |
30000.0 |
nM |
PMID[37468498] |
| NPT224 |
Individual protein |
Alpha-2c adrenergic receptor |
Homo sapiens |
AC50 |
> |
30000.0 |
nM |
PMID[37468498] |
| NPT30 |
Individual protein |
Cyclooxygenase-1 |
Homo sapiens |
Ki |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT267 |
Individual protein |
Neuropeptide Y receptor type 1 |
Homo sapiens |
AC50 |
> |
30000.0 |
nM |
PMID[37468498] |
| NPT239 |
Individual protein |
Cholecystokinin A receptor |
Homo sapiens |
AC50 |
> |
30000.0 |
nM |
PMID[37468498] |
| NPT264 |
Individual protein |
Muscarinic acetylcholine receptor M3 |
Homo sapiens |
AC50 |
> |
30000.0 |
nM |
PMID[37468498] |
| NPT218 |
Individual protein |
Adenosine A3 receptor |
Homo sapiens |
AC50 |
> |
30000.0 |
nM |
PMID[37468498] |
| NPT1410 |
Individual protein |
GABA receptor alpha-1 subunit |
Rattus norvegicus |
AC50 |
> |
30000.0 |
nM |
PMID[37468498] |
| NPT216 |
Individual protein |
Adenosine A1 receptor |
Homo sapiens |
AC50 |
> |
30000.0 |
nM |
PMID[37468498] |
| NPT230 |
Individual protein |
Bradykinin B2 receptor |
Homo sapiens |
AC50 |
> |
30000.0 |
nM |
PMID[37468498] |
| NPT228 |
Individual protein |
Norepinephrine transporter |
Homo sapiens |
AC50 |
> |
30000.0 |
nM |
PMID[37468498] |
| NPT2719 |
Individual protein |
Voltage-gated L-type calcium channel alpha-1C subunit |
Rattus norvegicus |
AC50 |
> |
30000.0 |
nM |
PMID[37468498] |
| NPT272 |
Individual protein |
Kappa opioid receptor |
Homo sapiens |
AC50 |
> |
30000.0 |
nM |
PMID[37468498] |
| NPT244 |
Individual protein |
Dopamine D3 receptor |
Homo sapiens |
AC50 |
> |
30000.0 |
nM |
PMID[37468498] |
| NPT261 |
Individual protein |
Monoamine oxidase A |
Homo sapiens |
AC50 |
> |
30000.0 |
nM |
PMID[37468498] |
| NPT2769 |
Individual protein |
Thromboxane A2 receptor |
Homo sapiens |
AC50 |
> |
30000.0 |
nM |
PMID[37468498] |
| NPT1647 |
Individual protein |
Vasopressin V2 receptor |
Homo sapiens |
AC50 |
> |
30000.0 |
nM |
PMID[37468498] |
| NPT246 |
Individual protein |
Dopamine transporter |
Homo sapiens |
AC50 |
> |
30000.0 |
nM |
PMID[37468498] |
| NPT262 |
Individual protein |
Muscarinic acetylcholine receptor M1 |
Homo sapiens |
AC50 |
> |
30000.0 |
nM |
PMID[37468498] |
| NPT1788 |
Individual protein |
Alpha-1a adrenergic receptor |
Homo sapiens |
AC50 |
> |
30000.0 |
nM |
PMID[37468498] |
| NPT292 |
Individual protein |
Serotonin 2c (5-HT2c) receptor |
Homo sapiens |
IC50 |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT292 |
Individual protein |
Serotonin 2c (5-HT2c) receptor |
Homo sapiens |
Ki |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT294 |
Individual protein |
Serotonin 6 (5-HT6) receptor |
Homo sapiens |
IC50 |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT295 |
Individual protein |
Serotonin transporter |
Homo sapiens |
IC50 |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT261 |
Individual protein |
Monoamine oxidase A |
Homo sapiens |
Ki |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT282 |
Individual protein |
MAP kinase ERK2 |
Homo sapiens |
IC50 |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT265 |
Individual protein |
Muscarinic acetylcholine receptor M4 |
Homo sapiens |
IC50 |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT276 |
Individual protein |
Angiotensin-converting enzyme |
Oryctolagus cuniculus |
Ki |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT303 |
Individual protein |
Vasopressin V1a receptor |
Homo sapiens |
IC50 |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT208 |
Individual protein |
Cytochrome P450 1A2 |
Homo sapiens |
Ki |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT212 |
Individual protein |
Cytochrome P450 2C9 |
Homo sapiens |
Ki |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT247 |
Individual protein |
Endothelin receptor ET-A |
Homo sapiens |
Ki |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT259 |
Individual protein |
Melanocortin receptor 4 |
Homo sapiens |
Ki |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT274 |
Individual protein |
Platelet activating factor receptor |
Homo sapiens |
Ki |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT240 |
Individual protein |
Cytochrome P450 2A6 |
Homo sapiens |
Ki |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT252 |
Individual protein |
Histamine H2 receptor |
Homo sapiens |
IC50 |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT219 |
Individual protein |
Alpha-1a adrenergic receptor |
Rattus norvegicus |
IC50 |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT295 |
Individual protein |
Serotonin transporter |
Homo sapiens |
AC50 |
> |
30000.0 |
nM |
PMID[37468498] |
| NPT248 |
Individual protein |
Estrogen receptor beta |
Homo sapiens |
IC50 |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT242 |
Individual protein |
Dopamine D1 receptor |
Homo sapiens |
Ki |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT251 |
Individual protein |
Histamine H1 receptor |
Homo sapiens |
Ki |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT233 |
Individual protein |
Carbonic anhydrase II |
Homo sapiens |
Ki |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT224 |
Individual protein |
Alpha-2c adrenergic receptor |
Homo sapiens |
Ki |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT278 |
Individual protein |
Cathepsin G |
Homo sapiens |
Ki |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT280 |
Individual protein |
Matrix metalloproteinase 9 |
Homo sapiens |
Ki |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT284 |
Individual protein |
Serine/threonine protein phosphatase 2B catalytic subunit, alpha isoform |
Homo sapiens |
Ki |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT14 |
Individual protein |
Tyrosine-protein kinase FYN |
Homo sapiens |
IC50 |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT287 |
Individual protein |
Leukocyte common antigen |
Homo sapiens |
Ki |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT218 |
Individual protein |
Adenosine A3 receptor |
Homo sapiens |
IC50 |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT221 |
Individual protein |
Alpha-1d adrenergic receptor |
Homo sapiens |
Ki |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT224 |
Individual protein |
Alpha-2c adrenergic receptor |
Homo sapiens |
IC50 |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT226 |
Individual protein |
Beta-2 adrenergic receptor |
Homo sapiens |
IC50 |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT234 |
Individual protein |
C-C chemokine receptor type 2 |
Homo sapiens |
IC50 |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT236 |
Individual protein |
C-C chemokine receptor type 5 |
Homo sapiens |
IC50 |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT208 |
Individual protein |
Cytochrome P450 1A2 |
Homo sapiens |
IC50 |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT110 |
Individual protein |
Cytochrome P450 2D6 |
Homo sapiens |
Ki |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT109 |
Individual protein |
Cytochrome P450 3A4 |
Homo sapiens |
Ki |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT244 |
Individual protein |
Dopamine D3 receptor |
Homo sapiens |
IC50 |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT245 |
Individual protein |
Dopamine D4 receptor |
Homo sapiens |
IC50 |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT108 |
Individual protein |
Estrogen receptor alpha |
Homo sapiens |
IC50 |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT249 |
Individual protein |
Glucocorticoid receptor |
Homo sapiens |
IC50 |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT249 |
Individual protein |
Glucocorticoid receptor |
Homo sapiens |
Ki |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT251 |
Individual protein |
Histamine H1 receptor |
Homo sapiens |
IC50 |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT13 |
Individual protein |
Tyrosine-protein kinase LCK |
Homo sapiens |
IC50 |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT288 |
Individual protein |
Serotonin 1a (5-HT1a) receptor |
Rattus norvegicus |
Ki |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT291 |
Individual protein |
Serotonin 2b (5-HT2b) receptor |
Homo sapiens |
Ki |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT296 |
Individual protein |
Sigma opioid receptor |
Homo sapiens |
IC50 |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT297 |
Individual protein |
Neurokinin 1 receptor |
Homo sapiens |
Ki |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT301 |
Individual protein |
Vascular endothelial growth factor receptor 1 |
Homo sapiens |
Ki |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT303 |
Individual protein |
Vasopressin V1a receptor |
Homo sapiens |
Ki |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT252 |
Individual protein |
Histamine H2 receptor |
Homo sapiens |
AC50 |
> |
30000.0 |
nM |
PMID[37468498] |
| NPT272 |
Individual protein |
Kappa opioid receptor |
Homo sapiens |
IC50 |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT145 |
Individual protein |
Mu opioid receptor |
Homo sapiens |
IC50 |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT281 |
Individual protein |
MAP kinase ERK1 |
Homo sapiens |
Ki |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT987 |
Individual protein |
Histamine H3 receptor |
Homo sapiens |
AC50 |
> |
30000.0 |
nM |
PMID[37468498] |
| NPT50 |
Individual protein |
Tyrosyl-DNA phosphodiesterase 1 |
Homo sapiens |
Potency |
n.a. |
127.6 |
nM |
PubChem BioAssay data set |
| NPT50 |
Individual protein |
Tyrosyl-DNA phosphodiesterase 1 |
Homo sapiens |
Potency |
n.a. |
143.2 |
nM |
PubChem BioAssay data set |
| NPT5301 |
Individual protein |
Motilin receptor |
Homo sapiens |
AC50 |
> |
30000.0 |
nM |
PMID[37468498] |
| NPT4729 |
Individual protein |
Cholecystokinin B receptor |
Homo sapiens |
AC50 |
> |
30000.0 |
nM |
PMID[37468498] |
| NPT542 |
Individual protein |
Progesterone receptor |
Homo sapiens |
AC50 |
> |
30000.0 |
nM |
PMID[37468498] |
| NPT29498 |
Single protein |
Interleukin-8 receptor B |
Homo sapiens |
IC50 |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT68 |
Individual protein |
Aldose reductase |
Rattus norvegicus |
Ki |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT98 |
Individual protein |
HERG |
Homo sapiens |
Ki |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT98 |
Individual protein |
HERG |
Homo sapiens |
AC50 |
> |
30000.0 |
nM |
PMID[37468498] |
| NPT4358 |
Individual protein |
Type-1 angiotensin II receptor |
Homo sapiens |
AC50 |
> |
30000.0 |
nM |
PMID[37468498] |
| NPT29430 |
Single protein |
Neuronal acetylcholine receptor protein alpha-4 subunit |
Homo sapiens |
AC50 |
> |
30000.0 |
nM |
PMID[37468498] |
| NPT98 |
Individual protein |
HERG |
Homo sapiens |
IC50 |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT69 |
Individual protein |
Matrix metalloproteinase-1 |
Homo sapiens |
IC50 |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT69 |
Individual protein |
Matrix metalloproteinase-1 |
Homo sapiens |
Ki |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT68 |
Individual protein |
Aldose reductase |
Rattus norvegicus |
IC50 |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT29498 |
Single protein |
Interleukin-8 receptor B |
Homo sapiens |
Ki |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT20859 |
Single protein |
Neuropeptide Y receptor type 2 |
Homo sapiens |
IC50 |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT5104 |
Individual protein |
Phosphodiesterase 3A |
Homo sapiens |
AC50 |
> |
30000.0 |
nM |
PMID[37468498] |
| NPT5975 |
Individual protein |
Cyclooxygenase-1 |
Rattus norvegicus |
AC50 |
= |
12999.9 |
nM |
PMID[37468498] |
| NPT29454 |
Single protein |
Deoxynucleoside triphosphate triphosphohydrolase SAMHD1 |
Homo sapiens |
Inhibition |
= |
6.509 |
% |
PMID[38318365] |
| NPT28814 |
Single protein |
Ghrelin receptor |
Homo sapiens |
AC50 |
> |
30000.0 |
nM |
PMID[37468498] |
| NPT20859 |
Single protein |
Neuropeptide Y receptor type 2 |
Homo sapiens |
Ki |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT92 |
Individual protein |
Serotonin 1a (5-HT1a) receptor |
Homo sapiens |
AC50 |
> |
30000.0 |
nM |
PMID[37468498] |
| NPT28550 |
Single protein |
Vasoactive intestinal polypeptide receptor 1 |
Homo sapiens |
Ki |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT29442 |
Protein complex group |
Glycine receptor |
Rattus norvegicus |
Ki |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT49 |
Individual protein |
DNA-(apurinic or apyrimidinic site) lyase |
Homo sapiens |
Potency |
n.a. |
501.2 |
nM |
PubChem BioAssay data set |
| NPT30151 |
Single protein |
Melanocortin receptor 3 |
Homo sapiens |
IC50 |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT30010 |
Single protein |
Calcitonin receptor |
Homo sapiens |
IC50 |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT543 |
Individual protein |
Pregnane X receptor |
Homo sapiens |
AC50 |
> |
30000.0 |
nM |
PMID[37468498] |
| NPT29442 |
Protein complex group |
Glycine receptor |
Rattus norvegicus |
IC50 |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT28398 |
Single protein |
Insulin receptor |
Rattus norvegicus |
Ki |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT30151 |
Single protein |
Melanocortin receptor 3 |
Homo sapiens |
Ki |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT28550 |
Single protein |
Vasoactive intestinal polypeptide receptor 1 |
Homo sapiens |
IC50 |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT28398 |
Single protein |
Insulin receptor |
Rattus norvegicus |
IC50 |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT30151 |
Single protein |
Melanocortin receptor 3 |
Homo sapiens |
AC50 |
> |
30000.0 |
nM |
PMID[37468498] |
| NPT425 |
Individual protein |
Serotonin 3a (5-HT3a) receptor |
Homo sapiens |
AC50 |
> |
30000.0 |
nM |
PMID[37468498] |
| NPT30010 |
Single protein |
Calcitonin receptor |
Homo sapiens |
Ki |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |